All
The Mainstream Patient: October 12
October 12th 2020This week’s edition of The Mainstream Patient features stories about a new toxic-free cosmetics bill in California, the benefits of benzoyl peroxide for acne, the legitimacy of collagen supplements, potential sunscreen changes by the FDA, plus more.
AbobotulinumtoxinA for oily forehead
October 9th 2020Dr. Katarina Kesty, St. Petersburg Skin and Laser, St. Petersburg, Fla., discusses her presentation at the 2020 virtual American Society for Dermatologic Surgery (ASDS) meeting about her research using abobotulinumtoxinA injections to combat oil on the forehead.
Weekly Roundup: September 21-25
September 25th 2020ICYMI, some of the content featured this week includes articles about how to choose a telemedicine vendor, the launch of an international COVID-19 dermatology registry, a study evaluating dupilumab’s durability versus cyclosporine in patients with atopic dermatitis, plus more.
AAD, NPF guidelines urge liver disease monitoring in psoriasis patients
September 25th 2020The latest guidelines for psoriasis from the American Academy of Dermatology and the National Psoriasis Foundation recommend physicians monitor their patients for liver disease when prescribed medication for psoriasis, such as methotrexate.
Cross-specialty collaboration key to tracking COVID-19 skin symptoms
September 24th 2020Esther Freeman, M.D., details the team effort made by the American Academy of Dermatology’s (AAD) COVID-19 Task Force to launch an international registry documenting skin manifestations in patients diagnosed with or suspected of COVID-19 infection.